LOGICAL REASONING AND REASONABLE ANSWERS CONSISTENT WITH DECLARED OBJECTIVES FOR THE BENEFIT OF MANKIND

The author presents both a technological innovation and a formula that enables the balancing of the interests of business, science, and the public. Both innovation and formula are destined for those decision makers who pursue logical reasoning, who provide reasonable answers consistent with the declared objectives to benefit mankind, and who truly want a substantial reduction of premature cancer death. These innovations in PET (Positron Emission Tomography) technology, known as 3D-CBS (three-dimensional complete body screening), will facilitate the detection of cancer at an early stage, potentially saving millions of lives. Such innovations offer a significant improvement in efficiency over the 4,000 PET devices currently used in health care facilities, which cannot detect cancer at an early stage and cannot save lives. The innovations are supported by feasibility proofs, economical advantages in health care cost reduction and in great advantages for the patient. The proposed formula optimizes the power of the inter-relationships between business, science and the public interest and puts the patient as first priority, rather than prioritizing business to the detriment of the patient, while satisfying all parties involved in the solution. This article demonstrates how the "technological innovations" and the "formula" are the most promising solution to the problem of premature cancer death. The author's solution is based on the irrefutable claim that it is possible to improve the efficiency of the 4,000 current PET devices (theoretically over 1,000 times and practically by 400 times), thus enabling the reduction of the radiation dose to permit safe screening of high risk patients and enabling identification of minimum abnormal metabolism that allows detection of cancer at an early stage when it is highly curable. Furthermore the innovation allows a lower cost per signal captured from the tumor marker, reducing examination costs, which, together with the other innovations, reduces health care cost to only $250,000 per additional life saved from premature cancer death (versus the current cost of $10 million per life saved), thus making the device more competitive in the market. The author presents explanations to questions asked at his seminars as to how to overcome the obstacles preventing the transfer of the benefit of innovation to the bed of the patient. For the past ten years industry has continued to build significantly less efficient imaging PET devices which cannot detect cancer at an early stage and cannot save lives, while the innovative 3D-CBS technology can prove the claimed efficiency improvement even by using material available at the time of its first publication a decade ago. It is therefore necessary to remove the obstacles of decision makers who provide "unreasonable answers" (or no answers at all), not based on "logical reasoning" consistent with declared objectives -obstacles which have delayed for over a decade the implementation of this technological solution, in spite of the numerous recognitions already obtained in the scientific and academic communities, demonstrations of the feasibility of the innovative sections proven by the author and even recently by experimental results obtained by industry (i.e., Siemens). Due to the importance of this seminar to the world, it is expected that by presenting this article during the series of courses on "Planetary Emergencies," broad enough awareness will finally be created about the validity of the author's scientific arguments that could already have saved many lives. Doing so, shortly we will be able to say that everything possible has been done to increase the efficiency of current PET targeted to early cancer detection by implementing in a single giant step all the innovations of the author that could have already benefitted mankind for a decade.